Navigation Links
Certain Childhood Cancers More Likely to Recur
Date:12/4/2009

Research and surveillance urged for at-risk patient groups

FRIDAY, Dec. 4 (HealthDay News) -- Some childhood cancers, particularly Ewing sarcomas and central nervous system tumors, carry the risk of late recurrence, U.S. researchers have found.

The study authors analyzed data from 12,795 five-year survivors of the most common pediatric cancers who were enrolled in the Childhood Cancer Survivor Study.

The researchers found that the overall cancer recurrence rate was 4.4 percent at 10 years and 6.2 percent at 20 years. But the recurrence rate at 20 years was much higher for astrocytomas (14.4 percent) and for Ewing sarcomas (13 percent), and much lower for kidney tumors (0.9 percent), non-Hodgkin lymphomas (2.4 percent) and neuroblastomas (2.6 percent).

"Future research is needed to determine the risk of recurrence in subgroups of survivors and the cost-effectiveness of long-term disease surveillance in at-risk patient groups because these factors need to be considered in long-term follow-up and transitional care plans," wrote Dr. Karen Wasilewski-Masker, of the Aflac Cancer Center and Blood Disorders Service, Children's Healthcare of Atlanta at Scottish Rite, and colleagues.

The study appears online Dec. 4 in the Journal of the National Cancer Institute.

More information

The Nemours Foundation has more about childhood cancer.



-- Robert Preidt



SOURCE: Journal of the National Cancer Institute, news release, Dec. 4, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved

Page: 1

Related medicine news :

1. Use of certain lipid measures not more effective in predicting coronary heart disease
2. Class Settlement Could Result in Considerable Savings for Certain Consumers of Prescription Pharmaceuticals
3. MU researchers studying model to learn why certain cancers become resistant to drugs
4. New All-Natural Dietary Supplement Made from Muscadine Grape Skins Helps Inhibit Growth of Certain Cancers
5. Effectiveness of most PTSD therapies is uncertain
6. Value of Most Post-Traumatic Stress Treatments Uncertain
7. Certain Seizure Patients Need Emergency CT Scan
8. Ipsen and Debiopharm Extend Their Agreement for the Exclusive Commercialization of Decapeptyl(R) (triptorelin pamoate) in Europe and Certain Other Territories
9. Certain Cholesterol Drugs Show Their Limits
10. ADHD Delays Growth of Certain Brain Areas
11. Stress hormone may hasten the progression of certain blood cancers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/18/2014)... (PRWEB) November 18, 2014 Financing ... focused on innovative financing for international development, has ... Directors. Membership includes six Directors: Mr. John Skibiak ... Bent of the Millennium Challenge Corporation, Mr. Pape ... Total Impact Advisors, Mr. Aron Betru of Financing ...
(Date:11/18/2014)... TN (PRWEB) November 18, 2014 ... company for pharmaceutical, nutraceutical, dietary supplements and more, ... awarded NSF International’s Good Manufacturing Practices (GMP) Registration ... Earning GMP registration from NSF International verifies the ... safety and quality compliance requirements of its clients ...
(Date:11/18/2014)... Hispanic women who,ve had at least five children are much ... than those who,ve had fewer children or none, a new ... Aggarwal of Wake Forest School of Medicine analyzed data on ... York City and San Diego. About 12 percent of them ... type of heart trouble called ventricular diastolic dysfunction -- an ...
(Date:11/18/2014)... Until recently, insect-transmitted Chagas disease was found mainly in Latin ... to the United States over the past few years. ... bite of the "kissing bug," which feeds on the faces ... that common bedbugs might be carriers as well. "We,ve ... Our next step is to determine whether they are, or ...
(Date:11/17/2014)... Home Care Assistance – Halton/Peel Region ( ... senior care, is advising seniors to make sure they ... the immune system and makes it more difficult to ... a greater concern at this time of year, when ... year’s influenza season (November to March), over 5,200 adults ...
Breaking Medicine News(10 mins):Health News:Financing for Development Corp. (F4D) Announces Board of Directors 2Health News:Financing for Development Corp. (F4D) Announces Board of Directors 3Health News:Financing for Development Corp. (F4D) Announces Board of Directors 4Health News:A+ Secure Packaging, LLC Earns NSF International Good Manufacturing Practices (GMP) Registration for Dietary Supplements and Certification for Sport 2Health News:Certain Heart Dysfunction More Likely in Hispanic Women With Many Kids: Study 2Health News:Bedbugs Could Be Potential New Source of Tropical Disease in U.S. 2Health News:Bedbugs Could Be Potential New Source of Tropical Disease in U.S. 3Health News:Home Care Assistance – Halton/Peel Region, a Top Provider of In-Home Care, Encourages Seniors to Get Annual Flu Shot 2Health News:Home Care Assistance – Halton/Peel Region, a Top Provider of In-Home Care, Encourages Seniors to Get Annual Flu Shot 3
... trials show some success in helping children , FRIDAY, ... effective in treating juvenile rheumatoid arthritis, according to studies ... (ACR) meeting in Boston. , One study found that ... rheumatoid arthritis, may be a well-tolerated treatment for children ...
... researchers have shown that an immunosuppressive drug used in ... patients with systemic lupus erythematosus (SLE). SLE results in ... joints and kidneys. Its cause is unknown. The findings ... American College of Rheumatology in Boston. , Our findings ...
... Rural/Metro,Corporation (Nasdaq: RURL ) announced it will ... 30, 2007 and fiscal 2007 fourth quarter,and 12 months ... on November,14, 2007. In conjunction, the Company will host ... at 9 a.m. (Pacific)/ 11 a.m.,(Eastern). Also on ...
... Hooper Holmes,Inc. (Amex: HH ), a leading ... the third quarter ended September 30,2007. Third quarter ... the corresponding period of 2006. The Company recorded a ... million, or $(0.16) per share,compared to a net loss ...
... The Signature,Wounds of Operation Iraqi Freedom and ... Veterans for America,s,"Trends in Treatment of ... trends adversely affecting servicemembers and veterans,suffering from ... - traumatic,brain injury (TBI) and psychological traumas., ...
... N.C., EXTON, Pa. and SAN DIEGO, Nov. 9 ... US,provider of oncology equipment sales and service, announced ... with Radiology Oncology Systems, Inc.,(ROS), an oncology and ... Inc., a US provider of oncology equipment service,and ...
Cached Medicine News:Health News:Drugs Can Ease Juvenile Rheumatoid Arthritis 2Health News:Rural/Metro to Host Conference Call to Discuss Results for First Quarter Fiscal 2008 and Fourth Quarter/Fiscal 2007 Year-End 2Health News:Hooper Holmes Announces Third Quarter 2007 Results 2Health News:Hooper Holmes Announces Third Quarter 2007 Results 3Health News:Hooper Holmes Announces Third Quarter 2007 Results 4Health News:Hooper Holmes Announces Third Quarter 2007 Results 5Health News:Hooper Holmes Announces Third Quarter 2007 Results 6Health News:Hooper Holmes Announces Third Quarter 2007 Results 7Health News:Report Release: Veterans for America Finds Care for PTSD and TBI Inadequate 2Health News:RS&A, Inc. Announces It Has Joined Radiology Oncology Systems, Inc. (ROS) and Acceletronics, Inc. in a Strategic Alliance to Better Serve Its Customers in the Southeastern US 2Health News:RS&A, Inc. Announces It Has Joined Radiology Oncology Systems, Inc. (ROS) and Acceletronics, Inc. in a Strategic Alliance to Better Serve Its Customers in the Southeastern US 3
(Date:11/18/2014)... 2014  AgeneBio, a pharmaceutical company developing innovative ... brain function, today announced that the Company,s founder ... PhD, has received the Society for Neuroscience,s Mika ... years, Dr. Gallagher,s research at Johns Hopkins and ... has led to advancements in the field of ...
(Date:11/17/2014)... Nov. 17, 2014 Asterias Biotherapeutics, Inc. (NYSE ... field of regenerative medicine, today announced that Jane ... Development, will participate in a live Google Hangout session ... discussing the latest progress in stem cell-based therapies for ... Hangout session is scheduled for Tuesday, November 18, 2014, ...
(Date:11/17/2014)... , November 17, 2014 ... Boston on 20 November   ... discovery and development company, is pleased to announce that ... as one of ten top projects in neuroscience by ... Grau will present an overview of the programme ...
Breaking Medicine Technology:AgeneBio Founder and Chief Scientific Officer Receives Society for Neuroscience's Mika Salpeter Lifetime Achievement Award 2AgeneBio Founder and Chief Scientific Officer Receives Society for Neuroscience's Mika Salpeter Lifetime Achievement Award 3Asterias Biotherapeutics to Participate in Live Google Hangout Discussion of Stem Cell-Based Therapies for Spinal Cord Injury 2Heptares First-in-Class Selective Muscarinic Agonists Chosen as one of top Neuroscience Projects to Watch 2
... AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX ), ("AcelRx"), a ... innovative therapies for the treatment of acute or breakthrough pain, ... ended December 31, 2010. Net loss for the ... common share, compared with a net loss of $3.7 million, ...
... 23, 2011 Actavis Group, an international generic pharmaceuticals ... the US Food & Drug Administration to market Valacyclovir ... 500mg and 1 gram, the generic equivalent of Valtrex® ... for the 12 months ending December 31, 2010, according ...
Cached Medicine Technology:AcelRx Pharmaceuticals Reports Fourth Quarter and Full-Year 2010 Financial Results 2AcelRx Pharmaceuticals Reports Fourth Quarter and Full-Year 2010 Financial Results 3AcelRx Pharmaceuticals Reports Fourth Quarter and Full-Year 2010 Financial Results 4AcelRx Pharmaceuticals Reports Fourth Quarter and Full-Year 2010 Financial Results 5AcelRx Pharmaceuticals Reports Fourth Quarter and Full-Year 2010 Financial Results 6Actavis Receives Approval of Valacyclovir Hydrochloride Tablets in the U.S. 2
For the quantitative determination of Alkaline Phosphatase in serum. Linearity: 800 IU/L at 37C. P-nitrophenyl phosphate substrate....
Storage temperature: 2 - 8C, linearity: 0 - 25 mg/dL, expected value: 3.5 - 7.0 mg/dL. Available with calibrator and number of test 125....
For determination of uric acid in serum, plasma or urine. For Hitachi 704 / 911. Available with Calibrator: Trucal U and controls: Trulab N and Trulab P....
For the quantitative determination of Uric Acid in serum. Linearity: 25 mg/dl....
Medicine Products: